Jul 27, 2021
(Part 2) What happens when CB1 Receptors are removed from the body? Or when the enzyme (FAAH) that breaks down your own endocannabinoids is no longer present in the body? Our guest, Iain McGregor, Professor of Psychopharmacology at University of Sydney & Academic Director at the Lambert Initiative for...
Jul 22, 2021
(Part 1) Sometimes a single story can do more than mountains of research data. Previous decades only allowed the research of cannabis when looking at it’s harm potential, however recent times have changed. Our guest, Iain McGregor, Professor of Psychopharmacology at University of Sydney & Academic Director at the
Jul 15, 2021
(1-on-1 Consulting Call) Alan Ao, PharmD moved into cannabis when he saw its potential being unlocked. With a unique dispensary model in mind, Alan is navigating the New Jersey waters as new markets come online. We discuss positioning a business for future markets, setting up to be adaptable if market changes come...
Jul 13, 2021
What is the DEA & FDA to do in a brand new industry that is so wide and varied? What they will actually do is the bigger question. We’re at a fork in the road, recreational markets vs prescribed drug markets. Will further discovery be allowed to progress organically? Or will federal regulations move in to set the...
Jul 8, 2021
(Part 2) With Carrie Cuttler, Ph.D., we
discuss the mental health effects of cannabis use on anxiety,
depression and motivation. Cover how university students can get
involved in cannabis research. And the mental vs physical effects
of pain and how cannabis can influence each of those.
Thank you for helping us pass...